Torinsson Naluai Åsa, Sabbag Shafir, Abrahamsson Sanna, Gudjónsdóttir Audur H, Arnell Henrik, Agardh Daniel
Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Core Facilities, University of Gothenburg, Gothenburg, Sweden.
BMC Med. 2025 Aug 29;23(1):507. doi: 10.1186/s12916-025-04261-1.
Celiac disease is associated with HLA-risk haplotypes, but non-HLA genes and environmental factors are also linked to disease susceptibility. In this study, we explore the molecular pathways involved in celiac disease by analyzing the differential expression of genes in both the gut and peripheral blood across various celiac disease phenotypes.
Whole genome RNA sequencing was performed on 283 samples from intestinal mucosa and peripheral blood from 72 cases with either active, potential, or treated celiac disease and 73 disease controls. Enrichr pathway analysis of top differentially expressed genes was performed.
Overall, 7565 genes in intestinal biopsies and 542 genes in blood samples were differentially expressed between cases and controls. Compared with controls, immunoglobulin heavy variable 5-51 (IGHV5-51) (p = 1.05 × 10) and tissue transglutaminase (TGM2) (p = 5.29 × 10), encoding for TG2, the main autoantigen in celiac disease, were two of the top up-regulated genes in intestinal biopsies from celiac cases. TGM2 was also slightly upregulated in blood cells from cases with active disease compared with controls (p = 0.05). The topmost differentially expressed genes in peripheral blood were HLA-DQB1, HLA-DQB2, and GSTM1. Among pathways identified containing transcriptionally differentiated genes were antioxidant defense systems (e.g., nuclear factor (erythroid-derived 2)-like 2 (Nrf2), glutathione, ergothioneine, and peroxisome metabolism), as well as MHC class 1 antigen presentation, amino acid transport, mTORC1, bilirubin and lipid metabolism, liver homeostasis, the complement system, and interferon signaling.
Differentially expressed genes in cases and controls indicate crosstalk between molecular pathways involved in antioxidant defense, immune regulation, and nutrient signaling in the pathogenesis of celiac disease.
乳糜泻与HLA风险单倍型相关,但非HLA基因和环境因素也与疾病易感性有关。在本研究中,我们通过分析不同乳糜泻表型的肠道和外周血中基因的差异表达,探索参与乳糜泻的分子途径。
对来自72例活动性、潜在性或经治疗的乳糜泻患者以及73例疾病对照的肠道黏膜和外周血的283个样本进行全基因组RNA测序。对差异表达最显著的基因进行Enrichr通路分析。
总体而言,病例组和对照组之间,肠道活检中有7565个基因、血液样本中有542个基因存在差异表达。与对照组相比,编码乳糜泻主要自身抗原TG2的免疫球蛋白重链可变区5-51(IGHV5-51)(p = 1.05×10)和组织转谷氨酰胺酶(TGM2)(p = 5.29×10)是乳糜泻病例肠道活检中上调最显著的两个基因。与对照组相比,活动性疾病患者血细胞中的TGM2也略有上调(p = 0.05)。外周血中差异表达最显著的基因是HLA-DQB1、HLA-DQB2和GSTM1。在鉴定出的包含转录分化基因的通路中,有抗氧化防御系统(如核因子(红细胞衍生2)样2(Nrf2)、谷胱甘肽、麦角硫因和过氧化物酶体代谢),以及MHC I类抗原呈递、氨基酸转运、mTORC1、胆红素和脂质代谢、肝脏稳态、补体系统和干扰素信号传导。
病例组和对照组中差异表达的基因表明,在乳糜泻发病机制中,参与抗氧化防御、免疫调节和营养信号传导的分子途径之间存在相互作用。